Clearside Biomedical, Inc. (CLSD) SEC Filing 8-K Material Event for the period ending Thursday, June 10, 2021

Clearside Biomedical, Inc.

CIK: 1539029 Ticker: CLSD

View differences made from one to another to evaluate Clearside Biomedical, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Clearside Biomedical, Inc..


Assess how Clearside Biomedical, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Clearside Biomedical, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors



Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Ticker: CLSD
CIK: 1539029
Form Type: 8-K Corporate News
Accession Number: 0000950170-21-000342
Submitted to the SEC: Thu Jun 10 2021 4:32:10 PM EST
Accepted by the SEC: Thu Jun 10 2021
Period: Thursday, June 10, 2021
Industry: Pharmaceutical Preparations
  1. Vote of Security Holders

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: